References
- BhoomibunchooCYospaiboonYThoongsuwanSIdiopathic polypoidal choroidal vasculopathy in Thai patients with clinical and angiographic choroidal neovascularizationClin Ophthalmol2017111131732228223776
- KohALeeWKChenLJEVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathyRetina20123281453146422426346
- OishiAKojimaHMandaiMComparison of the effect of ranibizumab and verteporfin for polypoidal choroidal vasculopathy: 12-month LAPTOP study resultsAm J Ophthalmol2013156464465123876867
- GomiFOshimaYMoriRInitial versus delayed photodynamic therapy in combination with ranibizumab for treatment of polypoidal choroidal vasculopathy: The Fujisan studyRetina20153581569157625830698
- KohALaiTYYTakahashiKEfficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: a randomized clinical trialJAMA Ophthalmol2017135111206121328983556
- LeeWKIidaTOguraYEfficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in the PLANET Study: A Randomized Clinical TrialJAMA Ophthalmol2018136778679329801063